CRISPR-Cas12a Possesses Unconventional DNase Activity that Can Be Inactivated by Synthetic Oligonucleotides is a research paper published in Molecular Therapy — Nucleic Acids (2020). On theSindex it has a DataRank of 0.561. It has been cited 41 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.561
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Heart, Lung, and Blood Institute
Grant: R01HL136652
National Institutes of Health
Grant: 5R01HL136652-04
Biodegradable nanoparticles, a genome editing platform to treat hemophilia
Ohio State University
National Institutes of Health
FWCI
1.35
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords